Publicacions en col·laboració amb investigadors/es de Paul Sabatier University (18)

2021

  1. 2-phenoxy-3-trichloromethylquinoxalines are antiplasmodial derivatives with activity against the apicoplast of plasmodium falciparum

    Pharmaceuticals, Vol. 14, Núm. 8

  2. Antiplasmodial 2-thiophenoxy-3-trichloromethyl quinoxalines target the apicoplast of Plasmodium falciparum

    European Journal of Medicinal Chemistry, Vol. 224

  3. Special Issue: 2019 Consortium for Trans-Pyrenean Investigations on Obesity and Diabetes

    Journal of Physiology and Biochemistry

2020

  1. Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties

    European Journal of Medicinal Chemistry, Vol. 206

2019

  1. Oral phenelzine treatment mitigates metabolic disturbances in mice fed a high-fat diet

    Journal of Pharmacology and Experimental Therapeutics, Vol. 371, Núm. 2, pp. 555-566

2018

  1. Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery

    European Journal of Medicinal Chemistry, Vol. 152, pp. 489-514

2017

  1. Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: Results from the Nutrient Gene Interactions in Human Obesity: Implications for dietary guidelines (NUGENOB) randomized trial

    American Journal of Clinical Nutrition, Vol. 106, Núm. 3, pp. 902-908

2016

  1. Exploring the scope of new arylamino alcohol derivatives: Synthesis, antimalarial evaluation, toxicological studies, and target exploration

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 6, Núm. 3, pp. 184-198

2014

  1. Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents

    Molecules, Vol. 19, Núm. 2, pp. 2166-2180

2013

  1. New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities

    Molecules, Vol. 18, Núm. 4, pp. 4718-4727

2012

  1. Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4- phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives

    Molecules, Vol. 17, Núm. 8, pp. 9451-9461

2011

  1. Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships

    Experimental Parasitology, Vol. 128, Núm. 2, pp. 97-103

  2. New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 15, pp. 4498-4502

  3. Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives

    Experimental Parasitology, Vol. 127, Núm. 4, pp. 745-751

2008

  1. Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives

    Experimental Parasitology, Vol. 118, Núm. 1, pp. 25-31

2007

  1. Detection and incidence of drug-induced agranulocytosis in hospital: A prospective analysis from laboratory signals

    European Journal of Clinical Pharmacology, Vol. 63, Núm. 3, pp. 221-228

  2. Expanding role for the apelin/APJ system in physiopathology

    Journal of Physiology and Biochemistry

  3. Influence of acute and chronic administration of benzylamine on glucose tolerance in diabetic and obese mice fed on very high-fat diet

    Journal of Physiology and Biochemistry, Vol. 63, Núm. 4, pp. 305-315